Lung cancer trials in Spain

In Spain 273 Also abroad 2733

273 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 1/2Not yet taking people in Spain
A clinical trial to learn more about the effects of DJI136 in people with extensive-stage small cell lung cancer
Where
Barcelona, Madrid, Valencia
Age
18 years and over
People
25 worldwide
Run by
Novartis Pharma AG
See details and how to join2025-523276-23-00 · EU 2025-523276-23-00
Phase 2Taking people
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
Where
A Coruña, Jaén, Majadahonda
Age
18 years and over
People
44 worldwide
Run by
ETOP IBCSG Partners Foundation
See details and how to joinNCT05718323 · EU 2022-502092-33-00
Phase 1/2Taking people
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
Where
Badalona, Hortaleza
Age
18 years and over
People
252 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07223047
Phase 1/2Taking people
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Where
Barcelona, Madrid
Age
12 years and over
People
500 worldwide
Run by
Turning Point Therapeutics, Inc.
See details and how to joinNCT03093116 · EU 2024-512606-25-00
Phase 3Taking people
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Where
Barcelona, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Valencia, Zaragoza
Age
18 years and over
People
180 worldwide
Run by
Nuvation Bio Inc.
See details and how to joinNCT07154706 · EU 2025-521971-29-00
Phase 3Taking people
Study of Treatment With Sacituzumab and Zimberelimab for Patients With Lung Cancer Confined to the Chest and Previously Operated on Who Were Not Disease-free.
Where
A Coruña, Alicante, Badalona, Barcelona, Bilbao, Elche, Granada, Jerez de la Frontera, Las Palmas De Gran Canaria, León, L'Hospitalet de Llobregat, Lugo, Madrid, Majadahonda, Ourense, Palma, Reus, Sabadell, Salamanca, Santa Cruz de Tenerife, Sevilla, Terrassa, Valencia, Valladolid, Vigo, Zaragoza
Age
18 years and over
People
129
Run by
Fundación GECP
See details and how to joinNCT06431633 · EU 2024-512960-75-00
Phase 1Taking people
Phase I open-label, multi-center study to evaluate the safety, tolerability, dosimetry, and preliminary activity of [177Lu]Lu-NNS309 in patients with pancreatic, lung, breast and colorectal cancers.
Where
Barcelona, Madrid
Age
18 years and over
People
76 worldwide
Run by
Novartis Pharma AG
See details and how to join2023-510356-23-00 · EU 2023-510356-23-00
Phase 3Taking people
Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.
Where
Barcelona, L'Hospitalet de Llobregat, Madrid, Oviedo, Santiago de Compostela, Seville, Valencia
Age
18 years and over
People
170 worldwide
Run by
Grupo Espanol de Tumores Neuroendocrinos
See details and how to joinNCT05918302 · EU 2022-502154-13-00
Phase 2Taking people
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment
Where
A Coruña, Barcelona, Madrid, Valencia
Age
18 years and over
People
80 worldwide
Run by
Advenchen Pharmaceuticals, LLC.
See details and how to joinNCT05363280 · EU 2023-509067-24-01
No phaseTaking people
Concomitant Use of Radiotherapy and Integrated Exercise - Lung Cancer
Where
Barcelona, Pamplona
Age
18 years and over
People
10
Run by
University of Deusto
See details and how to joinNCT07489391
Phase 2Not yet taking people in Spain
Study for Evaluating the Safety and Feasibility of Fecal Microbiota Transplant in Stage II-III NSCLC Patients Using ICI Responders as Donors (MIGRANT)
Where
Alicante, Badalona, Barcelona, Elche, Granada, L'Hospitalet de Llobregat, Lugo, Madrid, Majadahonda, Málaga, Murcia, Santa Cruz de Tenerife, Santiago de Compostela, Valencia, Vigo
Age
18 years and over
People
68
Run by
Fundación GECP
See details and how to joinNCT07247786 · EU 2025-521251-24-00
Phase 1/2Taking people
Phase 1/2 multicenter, two-arms, open-label, dose-escalation study of IDP-121 in combination with chemotherapy in patients with relapsed small cell lung cancer (SCLC) (MYCrocytic)
Where
Badalona, Barcelona, Las Palmas De Gran Canaria, Málaga, Murcia, Pamplona, Santa Cruz de Tenerife, Valencia
Age
18 years and over
People
60
Run by
Idp Discovery Pharma S.L.
See details and how to join2025-521902-17-00 · EU 2025-521902-17-00
Phase 2Taking people
Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy
Where
A Coruña, Alicante, Badalona, Barcelona, Bilbao, Girona, Granada, Jaén, Leganés, Lugo, Madrid, Majadahonda, Palma, Sabadell, Sevilla, Valencia
Age
18 years and over
People
19
Run by
Fundación GECP
See details and how to joinNCT05398094 · EU 2024-511268-10-00
Phase 3Taking people
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
Where
Barcelona, Majadahonda, Valencia
Age
18 years and over
People
180 worldwide
Run by
ETOP IBCSG Partners Foundation
See details and how to joinNCT05522660
Phase 2Taking people
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment
Where
L'Hospitalet de Llobregat, Madrid, Sevilla, Valencia
Age
18 years and over
People
60 worldwide
Run by
BioNTech SE
See details and how to joinNCT06841055 · EU 2024-518279-80-00
Phase 2/3Taking people
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination with Osimertinib as First-Line Treatment in Adult Participants with Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Where
Barcelona, L'Hospitalet de Llobregat, Madrid, Valencia
Age
18 years and over
People
50 worldwide
Run by
AbbVie Deutschland GmbH & Co. KG
See details and how to join2024-518586-10-00 · EU 2024-518586-10-00
Phase 1Taking people
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLC
Where
Badalona, Madrid, Seville, Valencia
Age
18 years and over
People
304 worldwide
Run by
AstraZeneca
See details and how to joinNCT04686305 · EU 2023-504949-31-00
Phase 3Taking people
Dose-Escalation Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized Trial
Where
Almería, Barakaldo, Girona, Las Palmas de Gran Canaria, Madrid, Murcia, Salamanca, Santander, Santiago de Compostela, Seville, Valencia
Age
18 years and over
People
300
Run by
Instituto de Investigación Biomédica de Salamanca
See details and how to joinNCT07015892
No phaseNot yet taking people in Spain
Effectiveness of a Multimodal Outpatient Supervised Physical Activity Program to Improve Tolerance and Efficacy of Chemotherapy in Adults With Breast, Lung and Colon Cancer
Where
Vic
Age
35 years to 65 years
People
70
Run by
University of Vic - Central University of Catalonia
See details and how to joinNCT07502963
No phaseTaking people
Unveiling Malnutrition and Metabolic Changes in Lung Cancer Patients: Setting the Basis for Precision Nutrition Models.
Where
Madrid, San Sebastián de los Reyes
Age
18 years to 85 years
People
180 worldwide
Run by
Fundación Investigación E Innovación Biomédica Hospital Universitario Infanta Sofia-Henares
See details and how to joinNCT07486947
No phaseTaking people
Clinical Outcomes and Quality Of Life After Minimally Invasive Segmentectomy Versus Lobectomy for Lung Cancer
Where
Madrid
Age
18 years and over
People
180
Run by
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
See details and how to joinNCT07477158
No phaseTaking people
Prospective Multicentre Study for the Application of Telomere Measurement Technology as a Tool for Lung Cancer Diagnosis
Where
Barcelona, Elche, Madrid, Oviedo, Santander, Toledo, Valencia
Age
45 years and over
People
1,200
Run by
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
See details and how to joinNCT07465848
No phaseTaking people
Pathological Response After Neoadjuvant Treatment on NSCLC
Where
A Coruña, Alicante, Badalona, Barakaldo, Barcelona, Las Palmas de Gran Canaria, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Valencia, Vigo
Age
18 years and over
People
150
Run by
Fundación GECP
See details and how to joinNCT05167487
No phaseTaking people
Study of Antitumor Immune Response After cCRT and IO Treatment in Non-resectable III Stage NSCLC Patients
Where
A Coruña, Alicante, Badalona, Barcelona, Bilbao, Ciudad Real, Ferrol, Girona, Las Palmas de Gran Canaria, Lugo, Madrid, Majadahonda, Oviedo, Santa Cruz de Tenerife, Seville, Valencia, Valladolid, Vigo
Age
18 years and over
People
50
Run by
Fundación GECP
See details and how to joinNCT06634199
Phase 1/2Taking people
Phase 1/2 Study to Evaluate TH9619 in the Treatment of Advanced Solid Tumors
Where
Barcelona, Madrid
Age
18 years and over
People
43 worldwide
Run by
One-carbon Therapeutics AB
See details and how to joinNCT07151040 · EU 2024-519639-40-00